CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 91 filers reported holding CUREVAC N V in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $174,001 | -34.5% | 25,476 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $265,460 | +132.0% | 25,476 | +55.2% | 0.00% | 0.0% |
| Q1 2023 | $114,433 | +8.8% | 16,418 | -5.9% | 0.00% | 0.0% |
| Q4 2022 | $105,175 | +59.4% | 17,442 | +107.1% | 0.00% | – |
| Q3 2022 | $66,000 | -84.7% | 8,421 | -73.3% | 0.00% | -100.0% |
| Q2 2022 | $430,000 | +4.1% | 31,592 | +50.0% | 0.00% | +50.0% |
| Q1 2022 | $413,000 | -26.2% | 21,057 | +29.0% | 0.00% | -33.3% |
| Q4 2021 | $560,000 | +5.3% | 16,317 | +67.5% | 0.00% | 0.0% |
| Q3 2021 | $532,000 | +76.2% | 9,739 | +136.9% | 0.00% | +50.0% |
| Q2 2021 | $302,000 | – | 4,111 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 3,134,780 | $286,707,000 | 46.92% |
| Ally Bridge Group (NY) LLC | 110,000 | $10,061,000 | 1.93% |
| Parametrica Management Ltd | 44,695 | $3,968,000 | 1.91% |
| Renaissance Capital LLC | 123,983 | $11,339,000 | 1.68% |
| Samsara BioCapital, LLC | 95,318 | $8,718,000 | 1.61% |
| Ikarian Capital, LLC | 360,000 | $32,925,000 | 1.11% |
| SECTOR GAMMA AS | 25,000 | $2,287,000 | 0.42% |
| Fosun International Ltd | 50,000 | $4,438,000 | 0.35% |
| Ikarian Capital, LLC | 100,000 | $9,145,000 | 0.31% |
| Baillie Gifford | 5,830,101 | $533,221,000 | 0.30% |